Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease

Abstract Coronary heart disease (CHD) is one of the main diseases causing morbidity and mortality globally, with oxidative damage and lipid peroxidation associated with oxidative stress and atherosclerosis. Cinnamomum migao is a Miao ethnomedicine that has been shown to provide relief from CHD symptoms. A gas chromatograph-mass spectrometer (GC-MS) was used to determine the chemical components of ten batches of migao fatty oil (MFO), yielding a total of 35 chemical constituents. The antioxidant activity of MFO in vitro was assessed using the DPPH· and ABTS·+ assay methods, and both indicated good antioxidant activity. The network pharmacology predicted the active constituents of MFO and their therapeutic influence on the mechanism of oxidative damage-induced coronary heart disease (OD-CHD). Six compounds were discovered in MFO, including tau-cadinol acetate and dodecanoic acid, which may play a role in OD-CHD by acting on lipids and atherosclerosis, the PI3K-Akt signalling pathway, and other pathways. In conclusion, our study lays the foundation for investigating the use of MFO in the treatment of OD-CHD.

Saved in:
Bibliographic Details
Main Authors: JIAN,Lina, GUO,Jiangtao, ZHANG,Yongping, LIU,Jie, LIU,Yao, XU,Jian
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Ciência e Tecnologia de Alimentos 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-20612022000101398
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0101-20612022000101398
record_format ojs
spelling oai:scielo:S0101-206120220001013982022-10-24Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart diseaseJIAN,LinaGUO,JiangtaoZHANG,YongpingLIU,JieLIU,YaoXU,Jian migao fatty oil oxidative damage-induced coronary heart disease antioxidant activity network pharmacology in vitro experiments Abstract Coronary heart disease (CHD) is one of the main diseases causing morbidity and mortality globally, with oxidative damage and lipid peroxidation associated with oxidative stress and atherosclerosis. Cinnamomum migao is a Miao ethnomedicine that has been shown to provide relief from CHD symptoms. A gas chromatograph-mass spectrometer (GC-MS) was used to determine the chemical components of ten batches of migao fatty oil (MFO), yielding a total of 35 chemical constituents. The antioxidant activity of MFO in vitro was assessed using the DPPH· and ABTS·+ assay methods, and both indicated good antioxidant activity. The network pharmacology predicted the active constituents of MFO and their therapeutic influence on the mechanism of oxidative damage-induced coronary heart disease (OD-CHD). Six compounds were discovered in MFO, including tau-cadinol acetate and dodecanoic acid, which may play a role in OD-CHD by acting on lipids and atherosclerosis, the PI3K-Akt signalling pathway, and other pathways. In conclusion, our study lays the foundation for investigating the use of MFO in the treatment of OD-CHD.info:eu-repo/semantics/openAccessSociedade Brasileira de Ciência e Tecnologia de AlimentosFood Science and Technology v.42 20222022-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-20612022000101398en10.1590/fst.89322
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author JIAN,Lina
GUO,Jiangtao
ZHANG,Yongping
LIU,Jie
LIU,Yao
XU,Jian
spellingShingle JIAN,Lina
GUO,Jiangtao
ZHANG,Yongping
LIU,Jie
LIU,Yao
XU,Jian
Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
author_facet JIAN,Lina
GUO,Jiangtao
ZHANG,Yongping
LIU,Jie
LIU,Yao
XU,Jian
author_sort JIAN,Lina
title Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
title_short Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
title_full Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
title_fullStr Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
title_full_unstemmed Using integrated GC-MS analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
title_sort using integrated gc-ms analysis, in vitro experiments, network pharmacology: exploring migao fatty oil active components/mechanisms against coronary heart disease
description Abstract Coronary heart disease (CHD) is one of the main diseases causing morbidity and mortality globally, with oxidative damage and lipid peroxidation associated with oxidative stress and atherosclerosis. Cinnamomum migao is a Miao ethnomedicine that has been shown to provide relief from CHD symptoms. A gas chromatograph-mass spectrometer (GC-MS) was used to determine the chemical components of ten batches of migao fatty oil (MFO), yielding a total of 35 chemical constituents. The antioxidant activity of MFO in vitro was assessed using the DPPH· and ABTS·+ assay methods, and both indicated good antioxidant activity. The network pharmacology predicted the active constituents of MFO and their therapeutic influence on the mechanism of oxidative damage-induced coronary heart disease (OD-CHD). Six compounds were discovered in MFO, including tau-cadinol acetate and dodecanoic acid, which may play a role in OD-CHD by acting on lipids and atherosclerosis, the PI3K-Akt signalling pathway, and other pathways. In conclusion, our study lays the foundation for investigating the use of MFO in the treatment of OD-CHD.
publisher Sociedade Brasileira de Ciência e Tecnologia de Alimentos
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-20612022000101398
work_keys_str_mv AT jianlina usingintegratedgcmsanalysisinvitroexperimentsnetworkpharmacologyexploringmigaofattyoilactivecomponentsmechanismsagainstcoronaryheartdisease
AT guojiangtao usingintegratedgcmsanalysisinvitroexperimentsnetworkpharmacologyexploringmigaofattyoilactivecomponentsmechanismsagainstcoronaryheartdisease
AT zhangyongping usingintegratedgcmsanalysisinvitroexperimentsnetworkpharmacologyexploringmigaofattyoilactivecomponentsmechanismsagainstcoronaryheartdisease
AT liujie usingintegratedgcmsanalysisinvitroexperimentsnetworkpharmacologyexploringmigaofattyoilactivecomponentsmechanismsagainstcoronaryheartdisease
AT liuyao usingintegratedgcmsanalysisinvitroexperimentsnetworkpharmacologyexploringmigaofattyoilactivecomponentsmechanismsagainstcoronaryheartdisease
AT xujian usingintegratedgcmsanalysisinvitroexperimentsnetworkpharmacologyexploringmigaofattyoilactivecomponentsmechanismsagainstcoronaryheartdisease
_version_ 1756392519899283456